risperidone has been researched along with Catatonia in 28 studies
Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.
Catatonia: A neuropsychiatric disorder characterized by one or more of the following essential features: immobility, mutism, negativism (active or passive refusal to follow commands), mannerisms, stereotypies, posturing, grimacing, excitement, echolalia, echopraxia, muscular rigidity, and stupor; sometimes punctuated by sudden violent outbursts, panic, or hallucinations. This condition may be associated with psychiatric illnesses (e.g., SCHIZOPHRENIA; MOOD DISORDERS) or organic disorders (NEUROLEPTIC MALIGNANT SYNDROME; ENCEPHALITIS, etc.). (From DSM-IV, 4th ed, 1994; APA, Thesaurus of Psychological Index Terms, 1994)
Excerpt | Relevance | Reference |
---|---|---|
"A 39-year-old man with schizophrenia developed severe catatonia, hyperthermia, muscle rigidity, tachycardia, leukocytosis, and elevated muscle enzyme levels while receiving zotepine therapy." | 7.73 | Zotepine-induced catatonia as a precursor in the progression to neuroleptic malignant syndrome. ( Chen, CC; Tsai, JH; Yang, MJ; Yang, P; Yen, JY, 2005) |
"A patient with schizoaffective disorder developed signs of catatonia while on a regimen of valproic acid, sertraline, and risperidone." | 7.70 | Catatonia-like events after valproic acid with risperidone and sertraline. ( Lauterbach, EC, 1998) |
" This woman developed severe catatonia under medication with a serotonergic/dopaminergic neuroleptic, risperidone, at a dose of up to 5 mg daily." | 7.70 | Catatonia under medication with risperidone in a 61-year-old patient. ( Bahro, M; Kämpf, C; Strnad, J, 1999) |
"A 59-year-old man with nonalcoholic steatohepatitis cirrhosis underwent an orthotopic liver transplant and experienced a complicated postoperative course, including a prolonged delirium." | 5.43 | Prolonged Delirium With Catatonia Following Orthotopic Liver Transplant Responsive to Memantine. ( Brown, GD; Muzyk, AJ; Preud'homme, XA, 2016) |
"The DSM-IV recognizes catatonia as a subtype of schizophrenia characterized by at least two of the following: motor immobility, excessive motor activity not influenced by external stimuli, and peculiarities of voluntary movement." | 5.37 | Risperidone and lorazepam concomitant use in clonazepam refractory catatonia: a case report. ( Fajardo, K; Grenier, E; John, V; Ko, E; Ryan, M, 2011) |
"Sibutramine is a serotonin and norepinephrine reuptake intake inhibitor approved for the management of obesity." | 5.35 | Catatonia and psychosis associated with sibutramine: a case report and pathophysiologic correlation. ( Lee, J; Lee, TS; Teoh, T, 2008) |
"Levetiracetam (Keppra) is a novel antiepileptic drug approved as adjunctive treatment for adults with partial onset seizures." | 5.33 | Catatonia induced by levetiracetam. ( Bruneau, MA; Chouinard, MJ; Clément, JF; Nguyen, DK, 2006) |
"We found only one small, short-term trial suggesting that risperidone may improve catatonic and positive symptoms scale scores amongst people with schizophrenia spectrum disorders and catatonic symptoms, but that ECT may result in greater improvement in the first three weeks of treatment." | 5.22 | Antipsychotics for schizophrenia spectrum disorders with catatonic symptoms. ( Caroff, SN; Gibson, RC; Huang, MW; Jayaram, MB, 2022) |
"Successful treatment of acute periodic catatonia was achieved with a lorazepam-diazepam protocol, and the patient remained in remission for a longer duration under clozapine treatment." | 3.85 | Periodic catatonia with long-term treatment: a case report. ( Chen, RA; Huang, TL, 2017) |
"A 39-year-old man with schizophrenia developed severe catatonia, hyperthermia, muscle rigidity, tachycardia, leukocytosis, and elevated muscle enzyme levels while receiving zotepine therapy." | 3.73 | Zotepine-induced catatonia as a precursor in the progression to neuroleptic malignant syndrome. ( Chen, CC; Tsai, JH; Yang, MJ; Yang, P; Yen, JY, 2005) |
"A patient with schizoaffective disorder developed signs of catatonia while on a regimen of valproic acid, sertraline, and risperidone." | 3.70 | Catatonia-like events after valproic acid with risperidone and sertraline. ( Lauterbach, EC, 1998) |
" This woman developed severe catatonia under medication with a serotonergic/dopaminergic neuroleptic, risperidone, at a dose of up to 5 mg daily." | 3.70 | Catatonia under medication with risperidone in a 61-year-old patient. ( Bahro, M; Kämpf, C; Strnad, J, 1999) |
"Risperidone with MECT was beneficial for the patient in our case." | 1.48 | A case report of schizoaffective disorder with ritualistic behaviors and catatonic stupor: successful treatment by risperidone and modified electroconvulsive therapy. ( Bai, Y; Yang, H; Yang, X; Zeng, Z, 2018) |
"A 59-year-old man with nonalcoholic steatohepatitis cirrhosis underwent an orthotopic liver transplant and experienced a complicated postoperative course, including a prolonged delirium." | 1.43 | Prolonged Delirium With Catatonia Following Orthotopic Liver Transplant Responsive to Memantine. ( Brown, GD; Muzyk, AJ; Preud'homme, XA, 2016) |
"Sibutramine is a serotonin and norepinephrine reuptake intake inhibitor approved for the management of obesity." | 1.35 | Catatonia and psychosis associated with sibutramine: a case report and pathophysiologic correlation. ( Lee, J; Lee, TS; Teoh, T, 2008) |
" We treated catatonic symptoms with drugs within the upper limit of dosage and electroconvulsive therapy (ECT) to determine the maximal response." | 1.34 | Maximal response to electroconvulsive therapy for the treatment of catatonic symptoms. ( Arai, H; Hatta, K; Miyakawa, K; Nakamura, H; Ota, T; Usui, C, 2007) |
"Levetiracetam (Keppra) is a novel antiepileptic drug approved as adjunctive treatment for adults with partial onset seizures." | 1.33 | Catatonia induced by levetiracetam. ( Bruneau, MA; Chouinard, MJ; Clément, JF; Nguyen, DK, 2006) |
"Treatment and course of catatonia in an adolescent patient with Prader-Willi Syndrome are presented." | 1.30 | Catatonia in an adolescent with Prader-Willi Syndrome. ( Bouman, NH; Dhossche, DM, 1997) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (14.29) | 18.2507 |
2000's | 13 (46.43) | 29.6817 |
2010's | 8 (28.57) | 24.3611 |
2020's | 3 (10.71) | 2.80 |
Authors | Studies |
---|---|
Huang, MW | 1 |
Gibson, RC | 1 |
Jayaram, MB | 1 |
Caroff, SN | 1 |
Faisal, M | 1 |
Pradeep, V | 1 |
O'Hanrahan, S | 1 |
Rice, T | 1 |
Crow, M | 1 |
Cardieri, B | 1 |
Acheampong, D | 1 |
Coffey, BJ | 1 |
Chen, RA | 1 |
Huang, TL | 1 |
Bai, Y | 1 |
Yang, X | 1 |
Zeng, Z | 1 |
Yang, H | 1 |
Kar, SK | 1 |
Saxena, S | 1 |
Trivedi, JK | 1 |
Brown, GD | 1 |
Muzyk, AJ | 1 |
Preud'homme, XA | 1 |
Carey, S | 1 |
Mall, GD | 1 |
Hake, L | 1 |
Benjamin, AB | 1 |
Adityanjee, A | 1 |
Krähenmann, R | 1 |
Küchenhoff, B | 1 |
Böker, H | 1 |
Schick, M | 1 |
Danivas, V | 1 |
Behere, RV | 1 |
Varambally, S | 1 |
Rao, NP | 1 |
Venkatasubramanian, G | 1 |
Gangadhar, BN | 1 |
Dada, MU | 1 |
Oluwole, L | 1 |
Obadeji, A | 1 |
Ajayi, OA | 1 |
Grenier, E | 1 |
Ryan, M | 1 |
Ko, E | 1 |
Fajardo, K | 1 |
John, V | 1 |
Odawara, T | 1 |
Holtmann, M | 1 |
Meyer, AE | 1 |
Pitzer, M | 1 |
Schmidt, MH | 1 |
Ellard, J | 1 |
Duggal, HS | 1 |
Gandotra, G | 1 |
Tsai, JH | 1 |
Yang, P | 1 |
Yen, JY | 1 |
Chen, CC | 1 |
Yang, MJ | 1 |
Chouinard, MJ | 1 |
Nguyen, DK | 1 |
Clément, JF | 1 |
Bruneau, MA | 1 |
Fink, M | 1 |
Taylor, MA | 1 |
Parraga, H | 1 |
Harris, K | 1 |
Hatta, K | 1 |
Miyakawa, K | 1 |
Ota, T | 1 |
Usui, C | 1 |
Nakamura, H | 1 |
Arai, H | 1 |
Lee, J | 1 |
Teoh, T | 1 |
Lee, TS | 1 |
Singh, D | 1 |
Forlano, R | 1 |
Athey, R | 1 |
Cook, EH | 1 |
Olson, K | 1 |
Pliskin, N | 1 |
Dhossche, DM | 1 |
Bouman, NH | 1 |
Lauterbach, EC | 1 |
Bahro, M | 1 |
Kämpf, C | 1 |
Strnad, J | 1 |
2 reviews available for risperidone and Catatonia
Article | Year |
---|---|
Antipsychotics for schizophrenia spectrum disorders with catatonic symptoms.
Topics: Adult; Antipsychotic Agents; Catatonia; Humans; Neuroleptic Malignant Syndrome; Risperidone; Schizop | 2022 |
[Organic catatonic disorder].
Topics: Adult; Anti-Anxiety Agents; Benzodiazepines; Bromocriptine; Catatonia; Dopamine Agonists; Dopamine A | 2003 |
26 other studies available for risperidone and Catatonia
Article | Year |
---|---|
Case of paediatric catatonia precipitated by antipsychotic withdrawal in a child with autism spectrum disorder.
Topics: Adolescent; Antipsychotic Agents; Autism Spectrum Disorder; Catatonia; Female; Humans; Lorazepam; Ri | 2021 |
High-Dose Benzodiazepines in Treatment of Malignant Catatonia in an Adolescent: Lorazepam, Clonazepam, and Differing Efficacy.
Topics: Adolescent; Anticonvulsants; Catatonia; Clonazepam; Humans; Lorazepam; Male; Risperidone; Treatment | 2021 |
Periodic catatonia with long-term treatment: a case report.
Topics: Antipsychotic Agents; Catatonia; Clozapine; Drug Therapy, Combination; Female; Haloperidol; Humans; | 2017 |
A case report of schizoaffective disorder with ritualistic behaviors and catatonic stupor: successful treatment by risperidone and modified electroconvulsive therapy.
Topics: Adult; Antipsychotic Agents; Catatonia; Ceremonial Behavior; Electroconvulsive Therapy; Humans; Male | 2018 |
Electroconvulsive treatment in catatonia of cerebrovasculo-coagulopathy: a case report.
Topics: Adult; Antipsychotic Agents; Catatonia; Cerebrovascular Disorders; Depression, Postpartum; Electroco | 2013 |
Prolonged Delirium With Catatonia Following Orthotopic Liver Transplant Responsive to Memantine.
Topics: Catatonia; Delirium; Excitatory Amino Acid Antagonists; Humans; Liver Transplantation; Male; Memanti | 2016 |
Caution is still needed when prescribing atypical antipsychotics.
Topics: Antipsychotic Agents; Catatonia; Clozapine; Humans; Neuroleptic Malignant Syndrome; Risperidone | 2008 |
Catatonia and mild neuroleptic malignant syndrome after initiation of long-acting injectable risperidone: case report.
Topics: Antipsychotic Agents; Catatonia; Delayed-Action Preparations; Female; Humans; Injections, Intramuscu | 2008 |
[Catatonic dilemma in a schizoaffective patient with combined lithium-risperidone administration].
Topics: Antimanic Agents; Antipsychotic Agents; Brain; Catatonia; Clozapine; Diagnosis, Differential; Dopami | 2010 |
Electroconvulsive therapy in the treatment of delirious mania: a report of 2 patients.
Topics: Adolescent; Antimanic Agents; Bipolar Disorder; Catatonia; Delirium; Electroconvulsive Therapy; Fema | 2010 |
Dexamethasone induced psychosis presenting with catatonic features.
Topics: Adult; Antipsychotic Agents; Catatonia; Dexamethasone; Diazepam; Female; Follow-Up Studies; GABA Mod | 2011 |
Risperidone and lorazepam concomitant use in clonazepam refractory catatonia: a case report.
Topics: Catatonia; Clonazepam; Drug Therapy, Combination; Female; Humans; Lorazepam; Risperidone; Young Adul | 2011 |
Risperidone-induced marked elevation of serum creatine kinase in adolescence. A case report.
Topics: Adolescent; Antipsychotic Agents; Catatonia; Creatine Kinase; Humans; Male; Psychotic Disorders; Ris | 2003 |
Movement disorders and the treatment of schizophrenia.
Topics: Antipsychotic Agents; Brain; Catatonia; Deep Brain Stimulation; Dyskinesia, Drug-Induced; Humans; Lo | 2004 |
Risperidone treatment of periodic catatonia.
Topics: Adult; Antipsychotic Agents; Catatonia; Dose-Response Relationship, Drug; Electroencephalography; Hu | 2005 |
Zotepine-induced catatonia as a precursor in the progression to neuroleptic malignant syndrome.
Topics: Antipsychotic Agents; Blood Chemical Analysis; Catatonia; Dibenzothiepins; Disease Progression; Feve | 2005 |
Catatonia induced by levetiracetam.
Topics: Adult; Anticonvulsants; Antipsychotic Agents; Catatonia; Drug Therapy, Combination; Epilepsies, Part | 2006 |
Neuroleptic malignant syndrome is malignant catatonia, warranting treatments efficacious for catatonia.
Topics: Adult; Antipsychotic Agents; Catatonia; Electroshock; Female; Humans; Neuroleptic Malignant Syndrome | 2006 |
Catatonia under treatment with risperidone.
Topics: Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Catatonia; Child; Child Behavio | 2006 |
Maximal response to electroconvulsive therapy for the treatment of catatonic symptoms.
Topics: Administration, Oral; Adult; Aged; Antipsychotic Agents; Catatonia; Diazepam; Dose-Response Relation | 2007 |
Catatonia and psychosis associated with sibutramine: a case report and pathophysiologic correlation.
Topics: Adult; Antipsychotic Agents; Appetite Depressants; Body Image; Body Weight; Catatonia; Cyclobutanes; | 2008 |
Neuroleptic malignant syndrome and catatonia in a patient with dementia.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Benzodiazepines; Catatonia; Chlorpromazine; Choline | 2008 |
Response of organic catatonia to risperidone.
Topics: Catatonia; Humans; Male; Middle Aged; Neurocognitive Disorders; Risperidone; Treatment Outcome | 1996 |
Catatonia in an adolescent with Prader-Willi Syndrome.
Topics: Adolescent; Antipsychotic Agents; Catatonia; Haloperidol; Humans; Lorazepam; Male; Neurologic Examin | 1997 |
Catatonia-like events after valproic acid with risperidone and sertraline.
Topics: Adult; Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Catatonia; Drug Interactions; D | 1998 |
Catatonia under medication with risperidone in a 61-year-old patient.
Topics: Antipsychotic Agents; Catatonia; Clozapine; Delusions; Dose-Response Relationship, Drug; Female; Hum | 1999 |